Join
Live feed
·
INSIDERFilingvia Quantisnow
Vor Biopharma Inc. logo

CHIEF MEDICAL OFFICER Attar Eyal C. sold $3,162 worth of shares (2,227 units at $1.42), decreasing direct ownership by 2% to 126,625 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VOR (Vor Biopharma Inc.) and more on Quantisnow.